Jennifer van Treese
Psychiatric/Mental Health · Oklahoma City, OKNPI 1588445068
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 234 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 13.1% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,331, more than ten times the $179 reported in 2023.
Across 234 payments — averaging $18.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$577
- AbbVie$483
- Teva Pharmaceuticals USA, Inc.$447
- Alkermes, Inc.$378
- Johnson & Johnson$306
- Vanda Pharmaceuticals Inc.$286
- plus $2K from 17 others
What the payments were for
- Food & beverage$4,414100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,414 in reported general payments places this provider in the 80th percentile of 231 psychiatric/mental health providers in Oklahoma.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RexultiBrexpiprazole | 15 | $24,686 |
| VraylarCariprazine Hcl | 16 | $23,241 |
| Aripiprazole | 93 | $2,652 |
| Duloxetine Hcl | 85 | $2,060 |
| Quetiapine Fumarate | 93 | $1,365 |
| Olanzapine OdtOlanzapine | 13 | $1,062 |
| Buspirone Hcl | 70 | $944 |
| Bupropion XlBupropion Hcl | 50 | $890 |
| Ziprasidone Hcl | 20 | $843 |
| Divalproex Sodium ErDivalproex Sodium | 18 | $811 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 11 | $803 |
| Olanzapine | 38 | $708 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 53 | $690 |
| Lurasidone Hcl | 25 | $626 |
| Mirtazapine | 33 | $562 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Otsuka America Pharmaceutical, Inc.Rexulti | $577 | $24,68615 claims |
| AbbVieVraylar | $483 | $23,24116 claims |
| Almatica Pharma LLCSertraline Hcl | $17 | $50280 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 231 psychiatric/mental health providers in Oklahoma.
Other psychiatric/mental health in Oklahoma City
- Sylvie MawohOklahoma City$14K
- Imelda GarnerOklahoma City$9K
- Kathryn SheltonOklahoma City$8K
- Nicole BrownOklahoma City$8K
- Ragina HolimanOklahoma City$7K
- Tierra PageOklahoma City$7K
- Kelsey WilsonOklahoma City$6K
- Jamie HolzOklahoma City$6K
- Robin Potter-KimballOklahoma City$6K
- Sue RollinsOklahoma City$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.